|1.||Long, Harry J: 2 articles (12/2003 - 08/2003)|
|2.||Siegel, M E: 2 articles (11/2001 - 07/2001)|
|3.||Luck, J V: 2 articles (11/2001 - 07/2001)|
|4.||Li, Wencheng: 1 article (09/2012)|
|5.||He, Xingjun: 1 article (09/2012)|
|6.||Shao, Guoqiang: 1 article (09/2012)|
|7.||Xu, Luwei: 1 article (09/2012)|
|8.||Huang, Peilin: 1 article (09/2012)|
|9.||Jia, Ruipeng: 1 article (09/2012)|
|10.||Liang, Kai: 1 article (09/2012)|
07/01/2007 - "In this pilot study the efficacy of intratumoral injection of 32-P chromic phosphate in 14 patiehts with refractory H&N carcinomas was investigated in terms of response rates and overall survival. "
10/01/1994 - "Adjuvant therapy with intraperitoneal (IP) chromic phosphate (P-32) instillation in both early and advanced carcinoma of the ovary requires adequate intra-abdominal distribution for maximum therapeutic benefit. "
10/01/1994 - "Chromic phosphate therapy in carcinoma of the ovary."
06/01/1992 - "Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging."
09/15/1991 - "Two women developed apparently isolated recurrences of ovarian carcinoma involving prior incisions after receiving intraperitoneal radioactive chromic phosphate (P-32) adjuvant therapy for early epithelial ovarian carcinoma. "
01/01/1956 - "[Trial therapy of malignant tumors of the bladder by local excision followed by infiltration of radioactive colloidal chromium phosphate]."
01/01/1996 - "Great particles [32P]chromic phosphate for treatment of solid tumors."
01/01/1985 - "Ten patients with intracranial cystic tumors underwent stereotactic intracavitary irradiation using 32P colloidal chromic phosphate. "
10/01/1975 - "Sixty-seven patients with disseminated cancer were randomly allocated to treatment with continuous closed chest drainage removing all fluid for 72 hours (PD) or pleural drainage for 72 hours with the instillation into the pleural space of radioactive colloidal chromic phosphate (PD + 32P). "
01/01/1959 - "[Pre- and post-operative infiltrations of the mediastinum with a suspension of radioactive chromium phosphate in therapy of cancer of the bronchi]."
|3.||Neoplasm Metastasis (Metastasis)
11/01/1990 - "The purpose of the study is to investigate the value of adjuvant radiotherapy given in the form of colloidal chromic phosphate 32P suspension administered via portal vein, in preventing the growth of occult metastases in the liver. "
09/15/1991 - "Isolated incisional metastases after intraperitoneal radioactive chromic phosphate therapy for ovarian carcinoma."
11/01/1990 - "In conclusion, 32P labeled colloidal chromic phosphate is expected to prevent liver metastases of completely resected colorectal cancer."
03/01/1962 - "[Effect of radioactive chromium phosphate on the metastasis of Brown-Pierce tumors]."
02/15/1999 - "In this early Phase II study, the authors investigated the efficacy of intratumoral injection of P-32 chromic phosphate in 17 patients with refractory solid tumors or solitary metastases in terms of response rates and overall survival. "
|4.||Aneurysmal Bone Cysts (Aneurysmal Bone Cyst)
01/01/2010 - "CT-guided injection of axial aneurysmal bone cysts with 32P chromic phosphate leads to excellent local lesion control. "
01/01/2010 - "The purpose of our study was to retrospectively examine the efficacy of intralesional injection of 32P chromic phosphate, a beta-emitting colloidal radiopharmaceutical, in the treatment of aneurysmal bone cysts of the axial skeleton. "
01/01/2010 - "Five patients with large aneurysmal bone cysts were managed with injection of 32P chromic phosphate into their tumors under CT guidance. "
03/01/2000 - "We report the nonoperative treatment of a recurrent, multilevel spinal aneurysmal bone cyst by injection of 32P chromic phosphate colloid into the cyst. "
10/01/1988 - "Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma."
12/01/1982 - "Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma."
12/01/1982 - "From December 15, 1975 to June 16, 1980, 20 evaluable patients with International Federation of Gynaecology and Obstetrics Stage I invasive adenocarcinoma of the ovary were entered into a prospective study, including pretherapy restaging peritoneoscopy followed by treatment with intraperitoneal chromic phosphate if there was no evidence of residual macroscopic tumor. "
|1.||1-ethyl-2,3-dioxopiperazine (P 32)
|4.||Technetium (Technetium 99m)
|1.||Drug Therapy (Chemotherapy)